M I Pharma Private Limited
About M I Pharma Private Limited
Data last updated:
M I Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2009PTC190502. Its GSTIN is 27AAFCM9278A1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bharat Nathalal Shah and Rajiv Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 402 – 403 Viva Hub Town Shankarwadi Jogeshwari, Mumbai, Maharashtra, India – 400060.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.47 Cr, a growth of 85% compared to the previous year. For the same year it recorded a net loss of ₹16.1 Lakh (net margin -4.6%) and EBITDA of -₹21.32 Lakh (EBITDA margin -6.2%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressUnit No. 402 – 403 Viva Hub Town Shankarwadi Jogeshwari, Mumbai, Maharashtra, India – 400060
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of M I Pharma Private Limited
The main business activity of M I Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of M I Pharma Private Limited FY 2025 filings available
M I Pharma Private Limited reported revenue of ₹3.47 Cr (up 85% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of M I Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 85% growth in the latest year. EBITDA fell 207% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of M I Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹21.32 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹16.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of M I Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of M I Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of M I Pharma Private Limited
M I Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thomas Baker (Biosciences) Private Limited | ₹3.48 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Dr. Brita Pharmaceutical Private Limited (OPC) | ₹3.48 Cr (FY 2025) | •••• | •••• | 533.0% | •••• | New Delhi, Delhi, India |
| Winsmed Pharmaceuticals Private Limited | ₹3.48 Cr (FY 2023) | •••• | •••• | 57.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Gupta Bros Druggist Private Limited | ₹3.47 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | New Delhi, Delhi, India |
| R.J. Distributors Private Limited | ₹3.47 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Thane, Maharashtra, India |
| M I Pharma Private Limited this company | ₹3.47 Cr (FY 2025) | •••• | •••• | 85.0% | •••• | Mumbai, Maharashtra, India |
| Teja Pharma Private Limited | ₹3.46 Cr (FY 2018) | •••• | •••• | -46.0% | •••• | Thiruvallur, Tamil Nadu, India |
| Sanatio Pharmaceuticals Private Limited | ₹3.46 Cr (FY 2024) | •••• | •••• | -54.0% | •••• | Mumbai, Maharashtra, India |
| Cezane Remedies Private Limited | ₹3.46 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Ahmedabad, Gujarat, India |
| Dexcel Devices Private Limited | ₹3.45 Cr (FY 2025) | •••• | •••• | 137.0% | •••• | Nagpur, Maharashtra, India |
| Rax Health Care Private Limited | ₹3.45 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Ghaziabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below M I Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of M I Pharma Private Limited
M I Pharma Private Limited is audited by RAM AGARWAL & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAM AGARWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of M I Pharma Private Limited
M I Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Nathalal Shah | Director | 16 Mar 2016 | 10 Years 6 Months | Current |
| Rajiv Kumar Sharma Also directs: RV Lifesciences Limited, Azad Hind Niyog Foundation | Director | 17 Aug 2023 | 3 Years 1 Months | Current |
| Neeta Bharat Shah | Director | 22 Jun 2023 | 3 Years 3 Months | Current |
Ownership and Shareholding of M I Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of M I Pharma Private Limited
M I Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at M I Pharma Private Limited
Employment history and EPFO contributions of people linked to M I Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on M I Pharma Private Limited
M I Pharma Private Limited has 13 board changes on record since 2009: 8 appointments and 5 cessations. The latest: Rajiv Kumar Sharma was appointed as Director on 17 Aug 2023.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for M I Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by M I Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of M I Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of M I Pharma Private Limited
M I Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCM9278A1ZB | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of M I Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about M I Pharma Private Limited
M I Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 February 2009 (17+ years old) and is registered under CIN U24239MH2009PTC190502.
M I Pharma reported revenue of ₹3.47 Cr for FY 2025 (up 85% YoY).
M I Pharma has 3 current directors:
- Bharat Nathalal Shah - Director
- Rajiv Kumar Sharma - Director
- Neeta Bharat Shah - Director
M I Pharma reported a net loss of ₹16.1 Lakh (net margin -4.6%) and EBITDA of -₹21.32 Lakh (EBITDA margin -6.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of M I Pharma is 13% over three years and 6% over five years. In the latest year (FY 2025) revenue rose 85%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of M I Pharma is 27AAFCM9278A1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of M I Pharma is U24239MH2009PTC190502. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
M I Pharma was incorporated on 23 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of M I Pharma by revenue are Thomas Baker (Biosciences) Private Limited, Dr. Brita Pharmaceutical Private Limited (OPC), Winsmed Pharmaceuticals Private Limited, Gupta Bros Druggist Private Limited, R.J. Distributors Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Rajiv Kumar Sharma was appointed as Director on 17 Aug 2023. Parmesh Kamalakar Adarkar ceased to be Director on 05 Jul 2023. Neeta Bharat Shah was appointed as Director on 22 Jun 2023. M I Pharma has 13 board changes on record in total.
The registered office of M I Pharma is at Unit No. 402 – 403 Viva Hub Town Shankarwadi Jogeshwari, Mumbai, Maharashtra, India – 400060.